Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 4 |
2024 | 3 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean
zhao hong ye
(45 results)?
Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma.
BMC Cancer. 2023 Oct 19;23(1):1009. doi: 10.1186/s12885-023-11476-z.
BMC Cancer. 2023.
PMID: 37858111
Free PMC article.
A CT-based radiomics approach to predict intra-tumoral tertiary lymphoid structures and recurrence of intrahepatic cholangiocarcinoma.
Xu Y, Li Z, Yang Y, Li L, Zhou Y, Ouyang J, Huang Z, Wang S, Xie L, Ye F, Zhou J, Ying J, Zhao H, Zhao X.
Xu Y, et al.
Insights Imaging. 2023 Oct 15;14(1):173. doi: 10.1186/s13244-023-01527-1.
Insights Imaging. 2023.
PMID: 37840098
Free PMC article.
Item in Clipboard
The MAPS-CRAFITY score: a novel efficacy predictive tool for unresectable hepatocellular carcinoma treated with targeted therapy plus immunotherapy.
Ouyang J, Yang Y, Zhou Y, Ye F, Wang Z, Li Q, Xu Y, Li L, Zhao X, Zhang W, Zhou A, Huang Z, Wang Y, Cai J, Zhao H, Zhou J.
Ouyang J, et al.
Hepatol Int. 2023 Dec;17(6):1519-1531. doi: 10.1007/s12072-023-10580-3. Epub 2023 Sep 14.
Hepatol Int. 2023.
PMID: 37707759
Item in Clipboard
The GRAPHS-CRAFITY score: a novel efficacy predictive tool for unresectable hepatocellular carcinoma treated with immunotherapy.
Yang Y, Li L, Xu Y, Ouyang J, Zhou Y, Ye F, Huang Z, Zhang W, Zhou A, Zhao X, Cai J, Wang Y, Zhou J, Zhao H.
Yang Y, et al.
Radiol Med. 2024 Feb;129(2):188-201. doi: 10.1007/s11547-023-01753-z. Epub 2024 Jan 5.
Radiol Med. 2024.
PMID: 38180570
Item in Clipboard
Reclassification of therapeutic response of unresectable hepatocellular carcinoma to anti-angiogenic therapy and immunotherapy using alpha RECIST.
Xu Y, Yang Y, Ouyang J, Zhou Y, Li L, Ye F, Yang H, Huang Z, Zhou A, Zhang W, Zhou J, Zhao X, Zhao H.
Xu Y, et al.
Eur Radiol. 2024 Apr;34(4):2244-2255. doi: 10.1007/s00330-023-10222-0. Epub 2023 Sep 23.
Eur Radiol. 2024.
PMID: 37740779
Item in Clipboard
Publisher Correction: Reclassification of therapeutic response of unresectable hepatocellular carcinoma to anti-angiogenic therapy and immunotherapy using alpha RECIST.
Xu Y, Yang Y, Ouyang J, Zhou Y, Li L, Ye F, Yang H, Huang Z, Zhou A, Zhang W, Zhou J, Zhao X, Zhao H.
Xu Y, et al.
Eur Radiol. 2024 Jan 29. doi: 10.1007/s00330-023-10575-6. Online ahead of print.
Eur Radiol. 2024.
PMID: 38285106
No abstract available.
Item in Clipboard
Cite
Cite